Evidence map›Paper›PMID 37666267›Full record

ArticleNuklearmedizin. Nuclear medicine2023

PET-Derived Increased Inflammation in Large Vessels is linked to Relapse-Free Survival in Patients with Giant Cell Arteritis.

Matthias Fröhlich, Marc Schmalzing, Andreas Buck, Thorsten A Bley, Konstanze V Guggenberger, Rudolf A Werner

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nuklearmedizin. Nuclear medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Matthias FröhlichUniversitätsklinikum Würzburg, Germany.
Marc SchmalzingDepartment of Internal Medicine II, Rheumatology and Clinical Immunology, University Hospital Würzburg, Germany.
Andreas BuckKlinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Würzburg, Germany.
Thorsten A Bley
Konstanze V GuggenbergerDepartment of Diagnostic and Interventional Radiology, University Hospital Würzburg, Germany.
Rudolf A WernerNuclear Medicine, Würzburg University Medical Center Clinic for Nuclear Medicine, Würzburg, Germany.
Universitätsklinikum Würzburg · DEKlinik und Poliklinik für Nuklearmedizin · DEStuttgart Observatory · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite anti-inflammatory treatment, patients with giant cell arteritis (GCA) experience relapse. We aimed to determine respective relapse predictors focusing on [ MATERIAL AND

methods21 therapy-naïve GCA patients received [

results8/21 (38.1 %) had relapse. Clinical parameters could not significantly discriminate between relapse vs no-relapse, including age (p = 0.9) or blood-based inflammatory markers (white blood cell counts [WBC] and c-reactive protein [CRP], p = 0.72, each). PETVAS score could also not differentiate between respective subgroups (p = 0.59). In a quantitative assessment, TBR

conclusion[

Indexed as

Giant Cell ArteritisChronic DiseaseFluorodeoxyglucose F18HumansInflammationLiverPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18

Identifiers

PMID37666267
PMCPMC10477020
OpenAlexW4386426608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.